Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Cosgrove, Y. Carmeli (2003)
The impact of antimicrobial resistance on health and economic outcomes.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 36 11
R. Colodner, Z. Samra, N. Keller, H. Sprecher, C. Block, N. Peled, T. Lazarovitch, R. Bardenstein, O. Schwartz-Harari, Y. Carmeli (2007)
First national surveillance of susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel.Diagnostic microbiology and infectious disease, 57 2
(2004)
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.American journal of infection control, 32 8
J. Durbin, G. Watson (1951)
Corrections to Part I: Testing for Serial Correlation in Least Squares Regression: IBiometrika, 38
J. Durbin, G. Watson (1950)
Testing for serial correlation in least squares regression. II.Biometrika, 38 1-2
R. Ben-Ami, J. Rodríguez-Baño, H. Arslan, J. Pitout, C. Quentin, E. Calbo, O. Azap, C. Arpin, Á. Pascual, D. Livermore, J. Garau, Y. Carmeli (2009)
A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 49 5
A. Mutnick, P. Rhomberg, H. Sader, Ronald Jones (2004)
Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).The Journal of antimicrobial chemotherapy, 53 2
S. Greenland, H. Morgenstern (1989)
Ecological bias, confounding, and effect modification.International journal of epidemiology, 18 1
R. Polk, Christina Fox, A. Mahoney, Jim Letcavage, C. MacDougall (2007)
Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 44 5
M. Zervos, E. Hershberger, D. Nicolau, D. Ritchie, L. Blackner, Elizabeth Coyle, A. Donnelly, Stephen Eckel, R. Eng, A. Hiltz, A. Kuyumjian, William Krebs, A. McDaniel, P. Hogan, T. Lubowski (2003)
Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 37 12
A. Hidrón, J. Edwards, J. Patel, T. Horan, D. Sievert, D. Pollock, S. Fridkin (2008)
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007Infection Control & Hospital Epidemiology, 29
P. Davies (2004)
Does increased use of antibiotics result in increased antibiotic resistance?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 39 1
L. Friedrich, Roger White, J. Bosso (1999)
Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 28 5
J. Rahal, C. Urban, D. Horn, K. Freeman, S. Segal-maurer, James Maurer, N. Mariano, Sheila Marks, J. Burns, Dana Dominick, Mimi Lim (1998)
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.JAMA, 280 14
S. Bhavnani, W. Callen, A. Forrest, K. Gilliland, D. Collins, J. Paladino, Jerome Schentag (2003)
Effect of fluoroquinolone expenditures on susceptibility of Pseudomonas aeruginosa to ciprofloxacin in U.S. hospitals.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 60 19
S. Cosgrove, G. Sakoulas, E. Perencevich, M. Schwaber, A. Karchmer, Y. Carmeli (2003)
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 36 1
J. Aeschlimann (2003)
The Role of Multidrug Efflux Pumps in the Antibiotic Resistance of Pseudomonas aeruginosa and Other Gram‐Negative BacteriaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 23
J. Hindler, Clinical (2005)
Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline
JR Aeschlimann (2003)
The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other Gram-negative bacteria. Insights from the Society of Infectious Diseases PharmacistsPharmacotherapy, 23
M. Schwaber, S. Navon-Venezia, D. Schwartz, Y. Carmeli (2005)
High Levels of Antimicrobial Coresistance among Extended-Spectrum-β-Lactamase-Producing EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 49
M. Neuhauser, R. Weinstein, R. Rydman, L. Danziger, G. Karam, J. Quinn (2003)
Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.JAMA, 289 7
Using susceptibility rates of Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae over time as markers, we assessed the significance of the change of susceptibility rates to imipenem, ceftriaxone, cefepime, piperacillin/tazobactam, and ciprofloxacin over time and the relationship to antibiotic use for the period 2000–2006. Antibiotic use–susceptibility relationships were assessed using longitudinal regression analysis. The variables “time” and define daily doses (DDD)/1,000 patient days for the specific drug related to the susceptibility rates of that particular model’s dependent variable were considered as the main effects, with significance determined at the 0.05 level. Decreases in susceptibility of the target organisms were common over the period of observation. Decreasing susceptibility trends over time were not statistically associated with the primary drug (e.g., organism susceptibility rate to imipenem with imipenem usage). However, secondary drug use was associated with susceptibility rates (e.g., susceptibility of E. cloacae to cefepime with piperacillin/tazobactam usage). These results suggest that antibiotic use–resistance relationships are influenced by the use of secondary antibiotics. Thus, a resistance problem may not be adequately addressed by simply altering the utilization of the primary antibiotic.
European Journal of Clinical Microbiology Infectious Diseases – Springer Journals
Published: Jun 10, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.